Dendreon's provenge got FDA approval early this week. This is used for prostate cancer treatment. I have followed the story from very beginning. The technology and clinical trial is very tricky and it is very difficult to be repeated. The company is selling the drug for $93,000 per treatment. That is why the market cap is about $7 bil right now.